undamentalytics Newsletter
Sign in

Hedge fund

Armistice Capital, LLC

13F for the quarter to June 30, 2026, filed August 14, 2026 · SEC CIK 1601086

Reported value
$3.6bn
97% in companies we cover
Positions we cover
292
Largest MDGL 4.3%
Copy, a year
+14.2%
S&P 500 +13.4%
Copy Sharpe ratio
0.61
S&P 500 0.71

How copying its 13F would have done

$10.0k$20.0k$40.0k 201520172019202120232025 $47.1k$43.5k
CopyS&P 500 $10,000 copying Armistice Capital, LLC's filed holdings in companies we cover from February 20, 2015, buying on the first trading day after each 13F was filed and holding until the next, against the S&P 500 (total return). Marked weekly, log scale. Before costs and taxes; misses trading within each quarter and anything 13F does not show (shorts, cash, bonds, non-US holdings).

Biggest drop −32.4% (S&P 500 −31.8%); beta 0.96; alpha +2.2% a year (t = 0.49); last 12 months +7.0% against +12.1%.

Reported value by quarter

Armistice Capital, LLC: 13F reported value Total value of all positions in each quarter's 13F, as filed (values before 2023 were filed in thousands of dollars and are converted).
$0 $1T $2T $3T $4T Reported value, 2014-12-31: $190.3M Reported value, 2015-03-31: $194.7M Reported value, 2015-06-30: $247.5M Reported value, 2015-09-30: $258.3M Reported value, 2015-12-31: $239M Reported value, 2016-03-31: $194.7M Reported value, 2016-06-30: $207.4M Reported value, 2016-09-30: $246.1M Reported value, 2016-12-31: $345.7M Reported value, 2017-03-31: $382.4M Reported value, 2017-06-30: $583.6M Reported value, 2017-09-30: $557.1M Reported value, 2017-12-31: $775.8M Reported value, 2018-03-31: $1.1B Reported value, 2018-06-30: $1.1B Reported value, 2018-09-30: $1.2B Reported value, 2018-12-31: $907M Reported value, 2019-03-31: $1.2B Reported value, 2019-06-30: $1.1B Reported value, 2019-09-30: $1.1B Reported value, 2019-12-31: $1.2B Reported value, 2020-03-31: $1.4B Reported value, 2020-06-30: $1.9B Reported value, 2020-09-30: $2.1B Reported value, 2020-12-31: $2.2B Reported value, 2021-03-31: $3.1B Reported value, 2021-06-30: $3.8B Reported value, 2021-09-30: $4B Reported value, 2021-12-31: $4.1B Reported value, 2022-03-31: $3.5B Reported value, 2022-06-30: $5.7B Reported value, 2022-09-30: $4B Reported value, 2022-12-31: $3.7T Reported value, 2023-03-31: $4.3B Reported value, 2023-06-30: $4B Reported value, 2023-09-30: $3.4B Reported value, 2023-12-31: $3.8B Reported value, 2024-03-31: $3.8B Reported value, 2024-06-30: $3.8B Reported value, 2024-09-30: $3.8B Reported value, 2024-12-31: $4.3B Reported value, 2025-03-31: $3.7B Reported value, 2025-06-30: $2.6B Reported value, 2025-09-30: $3.2B Reported value, 2025-12-31: $4.1B Reported value, 2026-03-31: $3B Reported value, 2026-06-30: $3.6B 2014-12-31 2017-06-30 2019-12-31 2022-06-30 2026-06-30 $3.6B
View chart data
Period Reported value
2014-12-31 $190.3M
2015-03-31 $194.7M
2015-06-30 $247.5M
2015-09-30 $258.3M
2015-12-31 $239M
2016-03-31 $194.7M
2016-06-30 $207.4M
2016-09-30 $246.1M
2016-12-31 $345.7M
2017-03-31 $382.4M
2017-06-30 $583.6M
2017-09-30 $557.1M
2017-12-31 $775.8M
2018-03-31 $1.1B
2018-06-30 $1.1B
2018-09-30 $1.2B
2018-12-31 $907M
2019-03-31 $1.2B
2019-06-30 $1.1B
2019-09-30 $1.1B
2019-12-31 $1.2B
2020-03-31 $1.4B
2020-06-30 $1.9B
2020-09-30 $2.1B
2020-12-31 $2.2B
2021-03-31 $3.1B
2021-06-30 $3.8B
2021-09-30 $4B
2021-12-31 $4.1B
2022-03-31 $3.5B
2022-06-30 $5.7B
2022-09-30 $4B
2022-12-31 $3.7T
2023-03-31 $4.3B
2023-06-30 $4B
2023-09-30 $3.4B
2023-12-31 $3.8B
2024-03-31 $3.8B
2024-06-30 $3.8B
2024-09-30 $3.8B
2024-12-31 $4.3B
2025-03-31 $3.7B
2025-06-30 $2.6B
2025-09-30 $3.2B
2025-12-31 $4.1B
2026-03-31 $3B
2026-06-30 $3.6B

Holdings and moves

CompanyShare of portfolioValueSharesChange in shares
MDGLMadrigal Pharmaceuticals, Inc.4.28%$154.6m288.0K+8.9% Added
SUPNSupernus Pharmaceuticals, Inc.3.40%$123.1m2.65M+39.6% Added
CYTKCytokinetics Inc2.83%$102.3m1.20M+57.1% Added
INCYIncyte2.82%$102.0m900.0K+37.0% Added
NBIXNeurocrine Biosciences Inc2.50%$90.3m535.8K−26.0% Reduced
TVTXTravere Therapeutics, Inc.2.47%$89.3m1.57M−67.9% Reduced
AGIOAgios Pharmaceuticals, Inc.2.46%$89.1m2.40M−11.6% Reduced
PTCTPTC Therapeutics, Inc.2.42%$87.4m1.07M−48.4% Reduced
UNHUnitedHealth Group2.10%$76.1m183.0K+23.6% Added
FRPTFreshpet, Inc.2.06%$74.5m1.26M+15.3% Added
DYNDyne Therapeutics, Inc.1.90%$68.6m3.09M−2.8% Reduced
AMZNAmazon1.88%$67.8m284.6K+8.6% Added
IMVTImmunovant, Inc.1.85%$66.9m1.74M−51.3% Reduced
RIGLRigel Pharmaceuticals Inc1.81%$65.4m1.67M+30.6% Added
TMOThermo Fisher Scientific1.70%$61.4m122.5K+33.9% Added
IRWDIronwood Pharmaceuticals Inc1.62%$58.7m13.93M−7.3% Reduced
HRMYHarmony Biosciences Holdings, Inc.1.57%$56.9m1.56M−3.7% Reduced
REGNRegeneron Pharmaceuticals1.55%$56.0m89.8K+148.6% Added
NKTRNektar Therapeutics1.40%$50.5m724.0K+25.3% Added
MLYSMineralys Therapeutics, Inc.1.30%$46.8m1.74M+47.6% Added
IMCRImmunocore Holdings plc1.25%$45.3m1.43M+20.2% Added
GOOGLAlphabet Inc. (Class A)1.25%$45.2m126.5K+6.7% Added
SLDBSolid Biosciences Inc.1.18%$42.7m4.28M+33.7% Added
MDBMongodb, Inc.1.16%$42.0m125.2K+16.7% Added
KURAKura Oncology, Inc.1.12%$40.3m3.68M−1.6% Reduced
XRAYDentsply Sirona Inc.1.08%$39.0m3.67M+22.4% Added
UBERUber0.99%$35.9m497.9K−4.0% Reduced
AXGNAxogen, Inc.0.99%$35.8m775.0K−17.2% Reduced
IRONDisc Medicine, Inc.0.93%$33.6m460.0K−14.2% Reduced
GTLBGitlab Inc.0.91%$32.8m1.07M+4.4% Added
FIVNFive9, Inc.0.91%$32.7m1.54M−3.5% Reduced
HUBSHubspot Inc0.90%$32.5m178.0K+38.5% Added
ALGNAlign Technology0.84%$30.4m180.3K+14.1% Added
MSFTMicrosoft Corporation0.83%$30.1m80.6K+64.9% Added
OFIXOrthofix Medical Inc.0.82%$29.8m3.26M+20.9% Added
HUMHumana0.80%$28.8m72.5K−48.7% Reduced
ANGOAngiodynamics Inc0.79%$28.6m2.20M+17.6% Added
WATWaters Corporation0.78%$28.1m75.0KNew
VSTMVerastem, Inc.0.74%$26.8m7.02M+53.0% Added
FDMT4d Molecular Therapeutics, Inc.0.74%$26.6m2.00M0.0%
NTLAIntellia Therapeutics, Inc.0.70%$25.4m1.50M+346.4% Added
WYNNWynn Resorts0.70%$25.3m261.1K+50.4% Added
TMCITreace Medical Concepts, Inc.0.70%$25.3m6.36M0.0%
AUTLAutolus Therapeutics plc0.66%$24.0m15.00M−5.1% Reduced
ARVNArvinas, Inc.0.64%$23.2m2.80M+41.4% Added
MGNXMacrogenics Inc0.64%$23.1m5.01M−16.7% Reduced
ANROAlto Neuroscience, Inc.0.63%$22.8m864.0K−5.3% Reduced
TOSTToast, Inc.0.62%$22.6m810.8K+40.4% Added
PATHUipath, Inc.0.60%$21.7m2.00M+55.7% Added
TSMTaiwan Semiconductor Manufacturing Co LTD0.57%$20.8m43.5K−29.0% Reduced
SSentinelone, Inc.0.57%$20.5m1.21M−36.5% Reduced
LENLennar0.55%$20.0m221.4K+25.1% Added
ISRGIntuitive Surgical0.54%$19.4m48.8K−6.2% Reduced
RHRH0.53%$19.2m116.6K+143.0% Added
ZETAZeta Global Holdings Corp.0.53%$19.0m965.3K+8677.6% Added
WDAYWorkday, Inc.0.52%$18.9m154.0K+108.2% Added
NBISNebius Group N.V.0.51%$18.5m67.0K−38.0% Reduced
INTCIntel0.50%$18.0m129.0K−42.4% Reduced
BABAAlibaba Group Holding Ltd0.45%$16.1m168.0K−17.6% Reduced
ILMNIllumina, Inc.0.44%$16.0m91.1KNew
PBHPrestige Consumer Healthcare Inc.0.44%$15.9m336.0KNew
GSKGSK plc0.43%$15.7m300.0K+27.1% Added
FWONKLiberty Media Corp0.43%$15.7m165.1KNew
ITGRInteger Holdings Corp0.43%$15.7m167.7KNew
CPRICapri Holdings Ltd0.43%$15.5m836.0K+27.1% Added
XERSXeris Biopharma Holdings, Inc.0.43%$15.5m1.96M+2.6% Added
SRRKScholar Rock Holding Corp0.42%$15.3m278.0K−17.5% Reduced
LYVLive Nation Entertainment0.41%$15.0m81.8KNew
NVONovo Nordisk A S0.41%$15.0m312.0KNew
TWSTTwist Bioscience Corp0.40%$14.6m142.0KNew
APPApplovin Corp0.40%$14.5m28.2K+15.6% Added
BCYCBicycle Therapeutics PLC0.40%$14.4m3.40M0.0%
PENNPenn Entertainment, Inc.0.40%$14.4m672.0K−57.4% Reduced
BMYBristol Myers Squibb0.37%$13.5m233.8K+14.0% Added
BBOTBridgebio Oncology Therapeutics, Inc.0.37%$13.4m1.76M+32.8% Added
CROXCrocs, Inc.0.37%$13.4m111.2K−28.1% Reduced
MUMicron Technology0.37%$13.4m11.6K−50.3% Reduced
BEBloom Energy0.37%$13.2m43.7K−8.5% Reduced
VERAVera Therapeutics, Inc.0.36%$12.9m300.0K+0.6% Added
TTWOTake TWO Interactive Software Inc0.34%$12.5m49.9KNew
SYRESpyre Therapeutics, Inc.0.34%$12.2m137.6K+13.8% Added
KYMRKymera Therapeutics, Inc.0.34%$12.2m106.3K+26.7% Added
VYGRVoyager Therapeutics, Inc.0.33%$12.0m3.44M−1.8% Reduced
MRVLMarvell Technology0.33%$11.9m40.0KNew
TERTeradyne0.33%$11.9m24.5K−44.1% Reduced
GNRCGenerac0.32%$11.7m39.9K−11.1% Reduced
RDDTReddit, Inc.0.32%$11.6m67.0K−4.3% Reduced
NUVBNuvation Bio Inc.0.31%$11.4m2.00M+15.2% Added
BSXBoston Scientific0.31%$11.3m265.2KNew
ELFE.l.f. Beauty, Inc.0.31%$11.3m152.7K+175.5% Added
NPCENeuropace Inc0.30%$11.0m692.0K0.0%
NTSKNetskope Inc0.30%$10.9m1.00MNew
ABNBAirbnb0.30%$10.7m74.7K+391.7% Added
FOXAFox Corporation (Class A)0.29%$10.6m202.9KNew
SHAKShake Shack Inc.0.28%$10.3m183.1KNew
SMTCSemtech Corp0.28%$10.1m62.4K+0.8% Added
EOLSEvolus, Inc.0.28%$10.0m1.44M+2.9% Added
DDOGDatadog, Inc.0.27%$9.8m37.7K−81.9% Reduced
BBYBest Buy0.27%$9.7m127.5K+146.9% Added
ZURAZura Bio Ltd0.27%$9.7m1.64M+8.6% Added
EWEdwards Lifesciences0.24%$8.9m97.9K−56.4% Reduced
NVDANVIDIA Corporation0.23%$8.3m41.7K−29.6% Reduced
PEGAPegasystems Inc0.23%$8.2m274.4K+30.4% Added
BLBlackline, Inc.0.22%$7.8m278.0K+65.5% Added
ARMKAramark0.21%$7.7m136.0KNew
RBLXRoblox Corp0.21%$7.6m139.9K+34.2% Added
INGNInogen Inc0.20%$7.1m1.10M−8.7% Reduced
NKENike, Inc.0.19%$7.0m170.7K−27.8% Reduced
SBUXStarbucks0.19%$7.0m68.1KNew
APPNAppian Corp0.19%$6.9m300.0KNew
BILLBILL Holdings, Inc.0.18%$6.6m181.6K−51.6% Reduced
ROSTRoss Stores0.17%$6.1m28.9K−39.7% Reduced
RPIDRapid Micro Biosystems, Inc.0.16%$5.8m3.33MNew
CTORCitius Oncology, Inc.0.16%$5.7m8.71M−5.3% Reduced
ORLYO'Reilly Automotive0.15%$5.3m57.7K−26.1% Reduced
RTBRTB Digital, Inc.0.15%$5.3m350.0KNew
AMATApplied Materials0.14%$5.1m7.1K−57.1% Reduced
DWTXDogwood Therapeutics, Inc.0.14%$5.0m3.13M−4.5% Reduced
LIVNLivanova PLC0.13%$4.8m58.5KNew
PONYPony AI Inc.0.13%$4.5m650.0K+21.3% Added
BTSGBrightspring Health Services, Inc.0.12%$4.4m63.4KNew
TSEMTower Semiconductor LTD0.12%$4.2m16.2K+8.9% Added
MCKMcKesson0.12%$4.2m5.6KNew
ESLAEstrella Immunopharma, Inc.0.11%$4.1m3.98M−3.0% Reduced
CRMDCormedix Inc.0.11%$3.9m500.0KNew
LEVILevi Strauss & Co0.11%$3.9m158.0K−27.5% Reduced
DHRDanaher Corporation0.11%$3.9m20.5KNew
LSCCLattice Semiconductor Corp0.10%$3.7m24.4KNew
STXSeagate Technology0.10%$3.7m3.9K−66.9% Reduced
SNDKSandisk0.10%$3.7m1.6K−72.3% Reduced
LRCXLam Research0.10%$3.6m8.3K−65.4% Reduced
TTMITTM Technologies Inc0.10%$3.6m19.0KNew
LITELumentum0.09%$3.2m3.8K−37.8% Reduced
WDCWestern Digital0.09%$3.2m5.0K−71.9% Reduced
STMStmicroelectronics N.V.0.09%$3.1m42.0KNew
ALABAstera Labs, Inc.0.08%$3.1m6.3KNew
MPWRMonolithic Power Systems, Inc.0.08%$3.0m2.2KNew
KYNBKyntra BIO, Inc.0.08%$3.0m400.0K0.0%
ENTGEntegris Inc0.08%$3.0m16.7KNew
RRXRegal Rexnord Corp0.08%$3.0m12.5KNew
REPLReplimune Group, Inc.0.08%$2.9m264.0KNew
BGSB&G Foods, Inc.0.07%$2.7m672.0KNew
VRCAVerrica Pharmaceuticals Inc.0.07%$2.6m426.3K−17.7% Reduced
GLWCorning Inc.0.07%$2.6m10.1K−67.1% Reduced
CNDTConduent Inc0.07%$2.5m1.69M+3.4% Added
INUVInuvo, Inc.0.06%$2.0m1.62MNew
ABTAbbott Laboratories0.06%$2.0m22.4KNew
ASMLAsml Holding NV0.06%$2.0m1.0K−55.9% Reduced
KLACKLA Corporation0.06%$2.0m6.6KNew
COHRCoherent Corp.0.05%$1.9m4.8KNew
CompanyBought (value)Shares
CYTKCytokinetics Inc$37.2m436.8K
SUPNSupernus Pharmaceuticals, Inc.$34.9m750.9K
REGNRegeneron Pharmaceuticals$33.5m53.7K
WATWaters Corporation$28.1m75.0K
INCYIncyte$27.6m243.2K
NTLAIntellia Therapeutics, Inc.$19.7m1.16M
ZETAZeta Global Holdings Corp.$18.8m954.3K
ILMNIllumina, Inc.$16.0m91.1K
PBHPrestige Consumer Healthcare Inc.$15.9m336.0K
FWONKLiberty Media Corp$15.7m165.1K
ITGRInteger Holdings Corp$15.7m167.7K
TMOThermo Fisher Scientific$15.5m31.0K
RIGLRigel Pharmaceuticals Inc$15.3m392.0K
MLYSMineralys Therapeutics, Inc.$15.1m560.0K
LYVLive Nation Entertainment$15.0m81.8K

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

CompanySold (value)Shares
TVTXTravere Therapeutics, Inc.−$188.9m−3.32M
PTCTPTC Therapeutics, Inc.−$81.8m−1.00M
IMVTImmunovant, Inc.−$70.5m−1.83M
DDOGDatadog, Inc.−$44.5m−170.9K
NBIXNeurocrine Biosciences Inc−$31.7m−188.2K
HUMHumana−$27.3m−68.8K
MDLNMedline Inc.−$25.1m−564.9K
ENREnergizer Holdings, Inc.−$19.7m−1.20M
PENNPenn Entertainment, Inc.−$19.4m−906.0K
METAMeta Platforms−$18.6m−32.6K
MUMicron Technology−$13.5m−11.7K
INTCIntel−$13.3m−95.0K
SSentinelone, Inc.−$11.7m−692.2K
AGIOAgios Pharmaceuticals, Inc.−$11.7m−316.0K
EWEdwards Lifesciences−$11.5m−126.9K

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

CompanyValue last quarterShares
MDLNMedline Inc.$25.1m564.9K
ENREnergizer Holdings, Inc.$19.7m1.20M
METAMeta Platforms$18.6m32.6K
IQVIQVIA$10.4m60.9K
GEHCGE HealthCare$8.4m118.3K
TENXTenax Therapeutics, Inc.$7.7m478.8K
NVSTEnvista Holdings Corp$6.7m264.0K
ICLRIcon PLC$6.7m60.3K
DVADaVita$6.6m43.0K
LCTXLineage Cell Therapeutics, Inc.$5.0m3.18M
ASAmer Sports, Inc.$4.9m148.8K
PRTAProthena Corp Public LTD Co$4.3m439.4K
KEYSKeysight Technologies$4.2m14.7K
MTSIMacom Technology Solutions Holdings, Inc.$3.7m16.8K
MCDMcDonald's$3.6m11.5K
CRBPCorbus Pharmaceuticals Holdings, Inc.$3.4m364.0K
FIXComfort Systems USA$3.2m2.4K
AMDAdvanced Micro Devices$3.2m15.6K
CIENCiena$3.2m8.1K
ONTOOnto Innovation Inc.$2.9m13.9K
VSXYVictoria's Secret & Co.$2.6m55.7K
HHyatt Hotels Corp$2.5m17.2K
WWWWolverine World Wide Inc$2.0m125.0K
SCLXScilex Holding Co$2.0m297.7K
QTEXQtrex Quantum Ltd.$1.8m4.14M
PRSUPursuit Attractions & Hospitality, Inc.$1.7m47.5K
VVOSVivos Therapeutics, Inc.$1.3m1.12M
GEVGE Vernova$1.3m1.5K
TRXTRX Gold Corp$945,261630.2K
OTLKOutlook Therapeutics, Inc.$857,7744.17M
  • Health Care68.3%
  • Technology14.7%
  • Consumer Discretionary8.2%
  • Communication Services3.5%
  • Consumer Staples2.8%
  • Industrials2.2%
  • Financials0.2%
  • Real Estate0.1%
  • Energy0.1%
  • Materials0.1%
  • Utilities0.0%

Share of the value held in companies we cover, by sector.

PeriodCopy, a yearS&P 500SharpeS&P 500Biggest dropBeta
Whole backtestFebruary 20, 2015 to November 2, 2026+14.2%+13.4%0.610.71−32.4%0.96
2018 onwardsJanuary 5, 2018 to November 2, 2026+13.3%+13.9%0.560.66−32.4%0.93
Last three yearsNovember 3, 2023 to November 2, 2026+17.6%+21.8%0.681.16−25.4%1.02
Last yearNovember 7, 2025 to November 2, 2026+10.6%+14.2%0.400.84−14.3%1.10

From SEC Form 13F data sets. A 13F lists long positions in US-listed shares at the quarter's end, filed up to 45 days later; it does not show shorts, cash, bonds, non-US holdings or trades within the quarter. Positions in companies outside our coverage are not listed here. Research, not investment advice.